Bg pattern

ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

5.0 (26)
Doctor

Giorgi Eremeishvili

Urology 22 years exp.

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Atosiban Altan 6.75 mg/0.9 ml Solution for Injection EFG

Atosiban

Read all of this leaflet carefully before you are given this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, midwife or pharmacist.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet:

  1. What is Atosiban Altan and what is it used for
  2. What you need to know before you are given Atosiban Altan
  3. How Atosiban Altan will be given to you
  4. Possible side effects
  5. Storage of Atosiban Altan
  6. Contents of the pack and further information

1. What is Atosiban Altan and what is it used for

Atosiban Altan contains atosiban. Atosiban may be used to delay premature birth of your baby. Atosiban is used in adult pregnant women, from the 24th week to the 33rd week of pregnancy.

Atosiban works by making the contractions of your uterus (womb) less strong. It also makes the contractions happen less often. This happens because it prevents the natural hormone called "oxytocin", which causes the uterus to contract, from working.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you are given Atosiban Altan

You should not be given Atosiban Altan

  • If you are less than 24 weeks pregnant.
  • If you are more than 33 weeks pregnant.
  • If your waters have broken (premature rupture of your membranes) and you have completed 30 weeks of pregnancy or more.
  • If your baby has an abnormal heart beat.
  • If you are bleeding from the vagina and your doctor wants you to go into labour so that your baby can be born immediately.
  • If you have a condition called severe pre-eclampsia and your doctor wants you to go into labour so that your baby can be born immediately. Severe pre-eclampsia is when you have very high blood pressure, fluid retention and/or protein in the urine.
  • If you have a condition called "eclampsia" which is similar to severe pre-eclampsia but you will also have fits. This will mean that labour should be started so that your baby can be born immediately.
  • If your baby has died.
  • If you have or may have an infection in the uterus (womb).
  • If your placenta is blocking the birth canal.
  • If your placenta is separating from the wall of your uterus.
  • If you or your baby have other conditions that may make it dangerous to continue with the pregnancy.
  • If you are allergic to atosiban or any of the other ingredients of this medicine (listed in section 6).

Do not use Atosiban Altan if you are affected by any of these conditions. If you are not sure, tell your doctor, midwife or pharmacist before you are given Atosiban Altan.

Warnings and precautions

Talk to your doctor, midwife or pharmacist before you are given atosiban:

  • If you think your waters have broken (premature rupture of your membranes).
  • If you have kidney or liver problems.
  • If you are between 24 and 27 weeks pregnant.
  • If you are pregnant with more than one baby.
  • If you have contractions again, treatment with atosiban can be repeated up to three times more.
  • If your baby is small for the length of your pregnancy.
  • If your uterus, after your baby is born, is not able to contract. This can cause bleeding.
  • If you are pregnant with more than one baby and/or are taking medicines that may delay the birth of your baby, such as medicines used for high blood pressure. This can increase the risk of fluid in the lungs (pulmonary oedema).

If you have any of these conditions (or are not sure), tell your doctor, midwife or pharmacist before you are given atosiban.

Children and adolescents

Atosiban has not been studied in pregnant women under 18 years of age.

Using Atosiban Altan with other medicines

Tell your doctor, midwife or pharmacist if you are taking, have recently taken or might take any other medicines.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, breast-feeding should be stopped during treatment with atosiban.

3. How Atosiban Altan will be given to you

Atosiban Altan will be given to you in a hospital by a doctor, nurse or midwife. They will decide how much you need. They will also make sure that the solution is clear and free of particles.

Atosiban will be given into a vein (intravenously) in three stages:

  • A first intravenous injection of 6.75 mg in 0.9 ml will be given slowly into your vein over one minute.
  • Then, an infusion of 18 mg per hour will be given over three hours.
  • Then, an infusion of 6 mg per hour will be given for up to 45 hours or until your uterine contractions have stopped.

The total duration of treatment should not be more than 48 hours.

Further treatments with atosiban can be given if you have contractions again. Treatment with atosiban can be repeated up to three times more.

During treatment with atosiban, your contractions and your baby's heart rate can be monitored.

It is recommended not to repeat treatment more than three times during a pregnancy.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The side effects seen in mothers were generally mild. There are no known side effects on the fetus or newborn.

The following side effects may occur with this medicine:

Very common(affects more than 1 in 10 people)

  • Feeling sick (nausea).

Common(affects less than 1 in 10 people)

  • Headache.
  • Feeling dizzy.
  • Flushing.
  • Being sick (vomiting).
  • Fast heart beat.
  • Low blood pressure. The signs may include feeling dizzy or faint.
  • Reaction at the injection site.
  • Increased blood sugar.

Uncommon(affects less than 1 in 100 people)

  • Increased temperature (fever).
  • Difficulty sleeping (insomnia).
  • Itching.
  • Rash.

Rare(affects less than 1 in 1,000 people)

  • Your uterus not being able to contract after the birth of your baby. This can cause bleeding.
  • Allergic reactions.

You may experience difficulty breathing or fluid in the lungs (pulmonary oedema), particularly if you are pregnant with more than one baby and/or are taking other medicines that may delay the birth of your baby, such as medicines used for high blood pressure.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Atosiban Altan

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date is the last day of the month shown.

Store in a refrigerator (2°C - 8°C).

Store in the original package to protect from light.

Once the ampoule is opened, the product should be used immediately.

Do not use this medicine if you notice that it contains particles or discolouration of the contents before administration.

6. Contents of the pack and further information

Composition of Atosiban Altan

The active substance is atosiban.

Each ampoule (0.9 ml solution for injection) contains 6.75 mg of atosiban (as acetate).

The other ingredients are: mannitol, hydrochloric acid and water for injections.

Appearance of Atosiban Altan and contents of the pack

Atosiban Altan 6.75 mg/0.9 ml solution for injection is a clear, colourless solution without particles. One pack contains a glass ampoule (2 ml) which contains 0.9 ml of solution.

Marketing Authorisation Holder

Altan Pharmaceuticals, S.A.

C/Cólquide, Nº6, Portal 2, 1ª Planta, Oficina F. Edificio Prisma

28230 Las Rozas (Madrid)

Spain

Manufacturer

ALTAN PHARMACEUTICALS, S.A

Avda de la Constitución 198-199, Polígono Industrial Monte Boyal

45950 Casarrubios del Monte (Toledo)

Spain

This medicine is authorised in the Member States of the EEA under the following names:

Spain:

Atosiban Altan 6.75 mg/0.9 ml solution for injection EFG

Belgium:

Atosiban Altan 6.75 mg/0.9 ml Solution injectable

France:

Atosiban Altan 6.75 mg/0.9 ml Solution injectable

Germany:

Atosiban Ibisqus 6.75 mg/0.9 ml Injektionslösung

Austria:

Atosiban Altan 6.75 mg/0.9 ml Injektionslösung

Italy:

Atosiban Ibisqus

United Kingdom:

Atosiban 6.75 mg/0.9 ml solution for injection

This leaflet was last revised in: October 2020

"Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/".

This information is intended only for healthcare professionals (see also section 3):

Instructions for use:

Before using Atosiban Altan, the solution should be examined to ensure it is clear and free of particles.

Atosiban Altan is administered intravenously in three successive stages:

  • An initial injection of 6.75 mg in 0.9 ml is given slowly into a vein over one minute.
  • An infusion of 18 mg per hour is given over three hours.
  • An infusion of 6 mg per hour is given for up to 45 hours or until uterine contractions have stopped.

The total duration of treatment should not be more than 48 hours. Further cycles of treatment with Atosiban Altan can be given if contractions occur again. It is recommended not to repeat treatment more than three times during a pregnancy.

Online doctors for ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution

Discuss questions about ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (53)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
5.0 (26)
Doctor

Giorgi Eremeishvili

Urology 22 years exp.

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

5.0 (43)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80

Get ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution?

ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution?

The active ingredient in ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution is atosiban. This information helps identify medicines with the same composition but different brand names.

Who manufactures ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution?

ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution is manufactured by Altan Pharmaceuticals Sa. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to ATOSIBAN ALTAN 6.75 mg/0.9 mL Injectable Solution?

Other medicines with the same active substance (atosiban) include ATOSIBAN ALTAN 37.5 mg/5 ml CONCENTRATE FOR INFUSION SOLUTION, ATOSIBAN EVER PHARMA 37.5 mg/5 ml CONCENTRATE FOR INFUSION SOLUTION, ATOSIBAN EVER PHARMA 6.75 mg/0.9 mL Injectable Solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media